Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
335
-
Total 13F shares, excl. options
-
86,773,703
-
Shares change
-
+478,756
-
Total reported value, excl. options
-
$6,755,702,862
-
Value change
-
+$42,211,359
-
Put/Call ratio
-
13.09%
-
Number of buys
-
149
-
Number of sells
-
-179
-
Price
-
$77.87
Significant Holders of RESMED INC - Common Stock (RMD) as of Q2 2017
406 filings reported holding RMD - RESMED INC - Common Stock as of Q2 2017.
RESMED INC - Common Stock (RMD) has 335 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86,773,703 shares
of 146,467,184 outstanding shares and own 59.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14,240,077 shares), VANGUARD GROUP INC (11,914,671 shares), Capital World Investors (10,086,707 shares), FMR LLC (5,542,582 shares), BAILLIE GIFFORD & CO (4,869,286 shares), STATE STREET CORP (4,605,287 shares), Bank of New York Mellon Corp (2,266,663 shares), COMMONWEALTH BANK OF AUSTRALIA (1,980,918 shares), NORTHERN TRUST CORP (1,473,925 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,241,649 shares).
This table shows the top 335 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.